Our findings, therefore, suggest that since BIN1 knockdown affects tau release, loss of BIN1 in Alzheimer’s disease will disrupt the functions of extracellular tau in addition to allowing phosphorylated tau to mislocalize to synapses and exert toxicity. The gene discussed is MAPT; the disease is Alzheimer disease.